La Jolla Pharmaceutical Stock Price - LJPC

4.63
-0.09 (-1.91%)
Upgrade to Real-Time
Regular Market
4.63
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
La Jolla Pharmaceutical Company LJPC NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.09 -1.91% 4.63 4.51 4.74 4.7272 4.72 10:14:40
Bid Price Ask Price Spread Spread % News
4.62 4.65 0.03 0.65% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
776 125,795 $ 4.59 $ 576,911 825,392 2.30 - 13.90
Last Trade Time Type Quantity Stock Price Currency
10:14:40 100 $ 4.63 USD

La Jolla Pharmaceutical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 128.85M 27.30M 25.69M $ 23.05M $ - -4.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 41.00 5.90%

more financials information »

La Jolla Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LJPC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.197.434.315.061,656,088-2.56-35.61%
1 Month6.958.104.316.48922,987-2.32-33.38%
3 Months5.128.103.36095.72815,803-0.49-9.57%
6 Months2.859.382.685.821,031,0421.7862.46%
1 Year5.3913.902.307.36940,442-0.76-14.1%
3 Years28.7841.3592.3013.96642,432-24.15-83.91%
5 Years22.6044.98992.3016.94493,163-17.97-79.51%

La Jolla Pharmaceutical Description

La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.